Showing posts with label Pleural. Show all posts
Showing posts with label Pleural. Show all posts

Saturday, January 1, 2011

Malignant Pleural Mesothelioma Survival Rate

Malignant pleural mesothelioma is the most common type of malignant mesothelioma. Many factors may be complex in determining the survival rate for this aggressive cancer; some are better understood than others. Estimates of average survival time range from one to two years; survival depends on fundamental factors such as the type and extent of spread of the mesothelioma. Only seven percent of people with this cancer survive to five years after diagnosis, but this outlook is gradually enhancing with some promising experimental treatments. Some people live well beyond five years from the time of diagnosis.

In general, younger age at diagnosis, absence of weight loss and little loss of lung function are linked with chances for increased survival. Stage I mesotheliomas, which have not spread to the lymph nodes or adjacent tissues and organs, also carry the best prognosis. The type of cell the cancer is comprised of can also sway survival. The epithelioid cell type has the best prognosis, the mixed or biphasic cell type the next best prognosis, and the sarcomatoid cell type the worst prognosis. The majority of malignant pleural mesotheliomas are of the epithelioid cell type.

Mesothelioma

Because this cancer takes so long to manifest, people are usually diagnosed at an older age and with more developed disease, potentially worsening the prognosis and the medicine options available. The more aggressive the treatment, the better the outcome may be, but in cases with cancer that has spread to other parts of the body, chemotherapy may be the only alternative. New drugs, such as the aggregate of Alimta with Platinol, have been shown to improve survival in malignant mesothelioma patients whose only choice is chemotherapy. A estimate of experimental treatments, such as immunotherapy and biotherapy, are currently being evaluated in clinical trials.

Malignant Pleural Mesothelioma Survival Rate

Friday, December 31, 2010

Misdiagnosed Pleural Mesothelioma

Let us take the scenario of a seventy-year-old man, who is a nonsmoker and otherwise fairly healthy, approaching the local doctor with complaints of persistent cough, chest congestion and weight loss. Other symptoms may consist of difficulty in swallowing and loss of appetite. The doctor has some options of diagnosis, but pleural mesothelioma, a lethal cancer that originates in the lining enveloping the lungs, may not be considered.

There are some reasons for this. Recognition of pleural mesothelioma as a cut off disease entity started as recently as the 1960s. Currently only about 3000 cases are reported annually in the United States. Many doctors may not have seen a particular such case while their career. The symptoms are similar to many lesser afflictions. The only general lead is that the disease seems to be more prevalent in the Pacific and Mid-Atlantic States. It is also known that the major cause for pleural mesothelioma is exposure to asbestos. But how much contact with the material leads to this disease is unclear. Even the family members of an asbestos laborer are at risk from the dust he carries home on his body and clothing.

Mesothelioma

This form of cancer has a long latent duration and the symptoms manifest only twenty to forty or more years after exposure to asbestos. This also vitiates the possibility of definite diagnosis.

Once the doctor eliminates the chances of other diseases and pursues the pleural mesothelioma line, the patient is subjected to a battery of tests and imaging procedures like x-ray and Ct scan. Fluid variety in the thoracic cavity is an indicator, but not conclusive. Confirmation can be obtained with a pleural (pleura is the membrane outside the lungs) biopsy using an electron microscope.

Since pleural mesothelioma is an aggressive cancer, early detection and immediate introduction of suitable administration are of requisite importance. The possibility of a doctor who fails to diagnose pleural mesothelioma or misdiagnoses it, being sued for curative malpractice cannot be totally ruled out. But regularly the law applicable is asbestos goods liability.

It is commonly suitable that pleural mesothelioma is a disease that is difficult to diagnose. To help the doctor, the patient should inform him at the very outset about exposure to asbestos, if any.

Misdiagnosed Pleural Mesothelioma

Sunday, December 26, 2010

Pleural Mesothelioma

Pleural Mesothelioma is the most base form of mesothelioma and practically always occurs due to asbestos exposure, and it is unfortunately one of the deadliest types of pulmonary cancer. As with any other invasive disease, earlier analysis often leads to additional rehabilitation options and an improved prognosis. Increased awareness has helped more habitancy seek the guidance of a physician, but some of the symptoms may manifest themselves later than others. The newest investigate is striving to diagnose Pleural Mesothelioma sooner which will allow quicker treatment.

The symptoms connected with Pleural Mesothelioma are fairly base to other breathing disorders as well, so many patients wait to seek treatment. Consumer advocacy groups are trying to publish reports and growth the awareness of the disease to encourage individuals to go to a doctor as soon as any of these symptoms appear. Shortness of breath may be one of the first signs, which is often followed by pain in the rib cage or lower back area. Later symptoms can include lumps of tissue directly under the skin exterior and painful coughing. Some more base signs such as unexplained weight loss are found in many other conditions and may not be adequate to cause a doctor to expect a more serious disease or cancer.

Mesothelioma

Diagnosis of Pleural Mesothelioma can occur as a effect of an imaging study that shows masses or shadowing on the lungs, but it often is found much later. Biopsies can be collected from masses and lumps of tissue, but this of procedure requires a doctor to find a suitable site to draw fluid. Some of the newest techniques are focused on enhanced imaging screens that would be offered to any personel that has ever knowingly been exposed to asbestos. High risk workers should caress their doctor and ask a scan. More investigate studies are placing an emphasis on studying the discrete blood levels and trying to decree if it will be possible to allow an early analysis based on the results.

Treating Pleural Mesothelioma is very similar to combating any other type of cancer. possible methods include radiation, chemotherapy, and even surgery. The most leading thing for individuals to understand about rehabilitation options is that the analysis will be much brighter with early diagnosis. Many treatments exist, but the best recipe will in effect depend on what stage the cancer is in. Any personel that has been exposed to asbestos needs to seek medical attention and decree if testing is necessary.

Pleural Mesothelioma

 
Redesigned by OGB